Visualitza per autor "Sanchez-Piedra, Carlos"
Ara mostrant els elements 1-4 d 4
-
Clinical factors associated with discontinuation of ts/ bDMARDs in rheumatic patients from the BIOBADASER III registry
Prior-Español, Agueda; Campos, J.; Manero, F. J.; Pérez‑García, C.; Bohórquez, C.; Sanchez-Piedra, Carlos; Busquets Pérez, Noemi (Nature Publishing Group, 2021-05-27) -
Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study
Alvaro-Gracia, Jose; Sanchez-Piedra, Carlos; Culqui L., Dante R; Roselló Pardo, Rosa; García Dorta, Alicia María; Campos, Cristina; Busquets Pérez, Noemi (BMJ Publishing Group, 2023-03) -
Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry
Valero Expósito, Marta; Sanchez-Piedra, Carlos; Freire, Mercedes; Colazo, María; Meriño-Ibarra, E; Busquets Pérez, Noemi (BMC, 2023-05-22) -
Real-world persistence of initial targeted therapy strategy in monotherapy versus combination therapy in patients with chronic inflammatory arthritis
Expósito, Lorena; Vela Casasempere, Paloma; moreno ramos, manuel josé; Campos, Cristina; Bohórquez Heras, Cristina; Sanchez-Piedra, Carlos; Busquets Pérez, Noemi (Wiley, 2024-02)